Healthcare provider profile · identity verified

Krista M Clark, DO

Family Practice · CHILLICOTHE, MO · NPI 1962727743

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	663	133
Atorvastatin Calcium	Atorvastatin Calcium	652	157
Lisinopril	Lisinopril	566	139
Pantoprazole Sodium	Pantoprazole Sodium	499	100
Gabapentin	Gabapentin	479	99
Amlodipine Besylate	Amlodipine Besylate	468	103
Losartan Potassium	Losartan Potassium	459	91
Carvedilol	Carvedilol	420	82
Rosuvastatin Calcium	Rosuvastatin Calcium	411	101
Metformin Hcl	Metformin Hcl	312	74
Potassium Chloride	Potassium Chloride	225	50
Furosemide	Furosemide	218	54
Famotidine	Famotidine	216	35
Duloxetine Hcl	Duloxetine Hcl	214	44
Montelukast Sodium	Montelukast Sodium	195	41
Ozempic	Semaglutide	195	34
Omeprazole	Omeprazole	188	52
Citalopram Hbr	Citalopram Hydrobromide	187	40
Albuterol Sulfate Hfa	Albuterol Sulfate	184	53
Trazodone Hcl	Trazodone Hcl	176	39
Metoprolol Succinate	Metoprolol Succinate	174	44
Hydrochlorothiazide	Hydrochlorothiazide	173	48
Fluoxetine Hcl	Fluoxetine Hcl	168	32
Meloxicam	Meloxicam	156	36
Eliquis	Apixaban	140	25
Metformin Hcl Er	Metformin Hcl	139	44
Tamsulosin Hcl	Tamsulosin Hcl	136	33
Simvastatin	Simvastatin	132	29
Alprazolam	Alprazolam	110	23
Buspirone Hcl	Buspirone Hcl	109	17
Venlafaxine Hcl Er	Venlafaxine Hcl	98	15
Pravastatin Sodium	Pravastatin Sodium	94	21
Pregabalin	Pregabalin	91	12
Alendronate Sodium	Alendronate Sodium	90	27
Ezetimibe	Ezetimibe	89	31
Oxybutynin Chloride Er	Oxybutynin Chloride	74	16
Clopidogrel	Clopidogrel Bisulfate	72	17
Bupropion Xl	Bupropion Hcl	70	20
Ropinirole Hcl	Ropinirole Hcl	70	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	27
Torsemide	Torsemide	66	13
Escitalopram Oxalate	Escitalopram Oxalate	63	12
Fluticasone Propionate	Fluticasone Propionate	62	29
Sertraline Hcl	Sertraline Hcl	61	13
Ventolin Hfa	Albuterol Sulfate	61	14
Breo Ellipta	Fluticasone/Vilanterol	60	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	26
Farxiga	Dapagliflozin Propanediol	59	12
Ibandronate Sodium	Ibandronate Sodium	56	22
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Allopurinol	Allopurinol	53	11
Hydroxyzine Hcl	Hydroxyzine Hcl	53	14
Donepezil Hcl	Donepezil Hcl	51	suppressed
Incruse Ellipta	Umeclidinium Bromide	50	suppressed
Memantine Hcl	Memantine Hcl	50	11
Ketoconazole	Ketoconazole	47	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Tramadol Hcl	Tramadol Hcl	45	15
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	12
Synthroid	Levothyroxine Sodium	43	15
Methocarbamol	Methocarbamol	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	13
Januvia	Sitagliptin Phosphate	39	suppressed
Spironolactone	Spironolactone	39	11
Tizanidine Hcl	Tizanidine Hcl	39	11
Prednisone	Prednisone	37	26
Warfarin Sodium	Warfarin Sodium	37	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	12
Clonazepam	Clonazepam	33	suppressed
Lovastatin	Lovastatin	31	11
Novolog Flexpen	Insulin Aspart	31	suppressed
Topiramate	Topiramate	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Cephalexin	Cephalexin	28	16
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Glimepiride	Glimepiride	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	20
Doxycycline Hyclate	Doxycycline Hyclate	25	21
Jardiance	Empagliflozin	25	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	11
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Risperidone	Risperidone	17	suppressed
Baclofen	Baclofen	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Atenolol	Atenolol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Mupirocin	Mupirocin	14	14
Valacyclovir	Valacyclovir Hcl	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Cefdinir	Cefdinir	13	12
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glipizide	Glipizide	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Anastrozole	Anastrozole	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error